🇺🇸 FDA
Patent

US 8895536

Compositions and methods for treating chronic inflammation and inflammatory diseases

granted A61KA61K31/19A61K31/192

Quick answer

US patent 8895536 (Compositions and methods for treating chronic inflammation and inflammatory diseases) held by Infirst Healthcare Limited expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/196, A61K31/215